Prestige Consumer Healthcare Inc.PBHNYSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +2.68% | +7.14% | -6.59% | -3.33% | -2.37% |
| Gross Profit Growth | +1.97% | +15.74% | -7.45% | -2.10% | -2.29% |
| EBITDA Growth | +4.99% | +1.71% | -0.04% | -2.99% | -18.68% |
| Operating Income Growth | +5.91% | +7.64% | -0.40% | -5.54% | -10.30% |
| Net Income Growth | +15.05% | +1.35% | -3.26% | -22.37% | -23.49% |
| EPS Growth | +14.95% | +2.02% | -2.04% | -21.82% | -20.33% |
| EPS Diluted Growth | +15.09% | +2.04% | -3.06% | -21.10% | -20.49% |
| Weighted Average Shares Growth | -0.29% | -0.27% | -0.82% | -1.26% | -3.46% |
| Weighted Average Shares Diluted Growth | -0.26% | -0.46% | -0.86% | -1.47% | -3.81% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -8.93% | -7.56% | +44.25% | -17.64% | +20.27% |
| Free Cash Flow Growth | -8.57% | -8.46% | +45.78% | -18.28% | +18.47% |
| Receivables Growth | -4.02% | +9.91% | -1.92% | +21.68% | +13.86% |
| Inventory Growth | +1.94% | +6.48% | +0.71% | +1.77% | +7.97% |
| Asset Growth | -0.31% | +2.53% | +3.75% | +3.78% | +4.96% |
| Book Value per Share Growth | +12.06% | +11.17% | +11.31% | +6.73% | +5.96% |
| Debt Growth | -15.36% | -8.37% | -5.45% | -1.87% | +5.08% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -2.05% | +0.11% | -7.15% | -1.09% | +8.74% |